Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: Results from a U.S. case-control study

James V. Lacey, Nancy Potischman, M. Patricia Madigan, Michael L. Berman, Rodrigue Mortel, Leo B. Twiggs, Rolland J. Barrett, George D. Wilbanks, John R. Lurain, Capri Mara Fillmore, Mark E. Sherman, Louise A. Brinton

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Objective: To assess whether circulating insulin-like growth factor-1 (IGF-1), IGF-2, insulin-like growth factor-binding protein-1 (IGFBP-1), or IGFBP-3 were associated with endometrial cancer in postmenopausal women. Study Design: Between 1987 and 1990, we conducted a case-control study of 405 women with endometrial cancer and 297 matched population-based controls. This analysis included 174 postmenopausal cases and 136 controls. Results: In logistic regression models adjusted for potential confounders, higher IGF-1 levels were not positively associated with endometrial cancer: odds ratio (OR) for the highest tertile versus the lowest tertile = 0.63, 95% confidence interval (CI) = 0.30-1.32. Endometrial cancer was inversely associated with IGF-2 (OR for the highest tertile = 0.35, 95% CI = 0.18-0.69) and IGFBP-3 (OR for the highest tertile = 0.40, 95% CI = 0.21-0.77), and not associated with IGFBP-1. Conclusion: Serum IGF-1, IGF-2, and IGFBP-3, but not IGFBP-1, were inversely associated with endometrial cancer in postmenopausal women. These associations and the potential role of the IGF system in endometrial proliferation and carcinogenesis warrant further research.

Original languageEnglish
Pages (from-to)607-612
Number of pages6
JournalCancer Epidemiology Biomarkers and Prevention
Volume13
Issue number4
StatePublished - Apr 1 2004
Externally publishedYes

Fingerprint

Insulin-Like Growth Factor Binding Proteins
Somatomedins
Endometrial Neoplasms
Case-Control Studies
Insulin-Like Growth Factor Binding Protein 1
Insulin-Like Growth Factor Binding Protein 3
Insulin-Like Growth Factor II
Odds Ratio
Confidence Intervals
Logistic Models
Population Control
Carcinogenesis
Serum
Research

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women : Results from a U.S. case-control study. / Lacey, James V.; Potischman, Nancy; Madigan, M. Patricia; Berman, Michael L.; Mortel, Rodrigue; Twiggs, Leo B.; Barrett, Rolland J.; Wilbanks, George D.; Lurain, John R.; Fillmore, Capri Mara; Sherman, Mark E.; Brinton, Louise A.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 13, No. 4, 01.04.2004, p. 607-612.

Research output: Contribution to journalArticle

Lacey, JV, Potischman, N, Madigan, MP, Berman, ML, Mortel, R, Twiggs, LB, Barrett, RJ, Wilbanks, GD, Lurain, JR, Fillmore, CM, Sherman, ME & Brinton, LA 2004, 'Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: Results from a U.S. case-control study', Cancer Epidemiology Biomarkers and Prevention, vol. 13, no. 4, pp. 607-612.
Lacey, James V. ; Potischman, Nancy ; Madigan, M. Patricia ; Berman, Michael L. ; Mortel, Rodrigue ; Twiggs, Leo B. ; Barrett, Rolland J. ; Wilbanks, George D. ; Lurain, John R. ; Fillmore, Capri Mara ; Sherman, Mark E. ; Brinton, Louise A. / Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women : Results from a U.S. case-control study. In: Cancer Epidemiology Biomarkers and Prevention. 2004 ; Vol. 13, No. 4. pp. 607-612.
@article{773aa8fcfb4548419e2c2310031bab61,
title = "Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: Results from a U.S. case-control study",
abstract = "Objective: To assess whether circulating insulin-like growth factor-1 (IGF-1), IGF-2, insulin-like growth factor-binding protein-1 (IGFBP-1), or IGFBP-3 were associated with endometrial cancer in postmenopausal women. Study Design: Between 1987 and 1990, we conducted a case-control study of 405 women with endometrial cancer and 297 matched population-based controls. This analysis included 174 postmenopausal cases and 136 controls. Results: In logistic regression models adjusted for potential confounders, higher IGF-1 levels were not positively associated with endometrial cancer: odds ratio (OR) for the highest tertile versus the lowest tertile = 0.63, 95{\%} confidence interval (CI) = 0.30-1.32. Endometrial cancer was inversely associated with IGF-2 (OR for the highest tertile = 0.35, 95{\%} CI = 0.18-0.69) and IGFBP-3 (OR for the highest tertile = 0.40, 95{\%} CI = 0.21-0.77), and not associated with IGFBP-1. Conclusion: Serum IGF-1, IGF-2, and IGFBP-3, but not IGFBP-1, were inversely associated with endometrial cancer in postmenopausal women. These associations and the potential role of the IGF system in endometrial proliferation and carcinogenesis warrant further research.",
author = "Lacey, {James V.} and Nancy Potischman and Madigan, {M. Patricia} and Berman, {Michael L.} and Rodrigue Mortel and Twiggs, {Leo B.} and Barrett, {Rolland J.} and Wilbanks, {George D.} and Lurain, {John R.} and Fillmore, {Capri Mara} and Sherman, {Mark E.} and Brinton, {Louise A.}",
year = "2004",
month = "4",
day = "1",
language = "English",
volume = "13",
pages = "607--612",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "4",

}

TY - JOUR

T1 - Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women

T2 - Results from a U.S. case-control study

AU - Lacey, James V.

AU - Potischman, Nancy

AU - Madigan, M. Patricia

AU - Berman, Michael L.

AU - Mortel, Rodrigue

AU - Twiggs, Leo B.

AU - Barrett, Rolland J.

AU - Wilbanks, George D.

AU - Lurain, John R.

AU - Fillmore, Capri Mara

AU - Sherman, Mark E.

AU - Brinton, Louise A.

PY - 2004/4/1

Y1 - 2004/4/1

N2 - Objective: To assess whether circulating insulin-like growth factor-1 (IGF-1), IGF-2, insulin-like growth factor-binding protein-1 (IGFBP-1), or IGFBP-3 were associated with endometrial cancer in postmenopausal women. Study Design: Between 1987 and 1990, we conducted a case-control study of 405 women with endometrial cancer and 297 matched population-based controls. This analysis included 174 postmenopausal cases and 136 controls. Results: In logistic regression models adjusted for potential confounders, higher IGF-1 levels were not positively associated with endometrial cancer: odds ratio (OR) for the highest tertile versus the lowest tertile = 0.63, 95% confidence interval (CI) = 0.30-1.32. Endometrial cancer was inversely associated with IGF-2 (OR for the highest tertile = 0.35, 95% CI = 0.18-0.69) and IGFBP-3 (OR for the highest tertile = 0.40, 95% CI = 0.21-0.77), and not associated with IGFBP-1. Conclusion: Serum IGF-1, IGF-2, and IGFBP-3, but not IGFBP-1, were inversely associated with endometrial cancer in postmenopausal women. These associations and the potential role of the IGF system in endometrial proliferation and carcinogenesis warrant further research.

AB - Objective: To assess whether circulating insulin-like growth factor-1 (IGF-1), IGF-2, insulin-like growth factor-binding protein-1 (IGFBP-1), or IGFBP-3 were associated with endometrial cancer in postmenopausal women. Study Design: Between 1987 and 1990, we conducted a case-control study of 405 women with endometrial cancer and 297 matched population-based controls. This analysis included 174 postmenopausal cases and 136 controls. Results: In logistic regression models adjusted for potential confounders, higher IGF-1 levels were not positively associated with endometrial cancer: odds ratio (OR) for the highest tertile versus the lowest tertile = 0.63, 95% confidence interval (CI) = 0.30-1.32. Endometrial cancer was inversely associated with IGF-2 (OR for the highest tertile = 0.35, 95% CI = 0.18-0.69) and IGFBP-3 (OR for the highest tertile = 0.40, 95% CI = 0.21-0.77), and not associated with IGFBP-1. Conclusion: Serum IGF-1, IGF-2, and IGFBP-3, but not IGFBP-1, were inversely associated with endometrial cancer in postmenopausal women. These associations and the potential role of the IGF system in endometrial proliferation and carcinogenesis warrant further research.

UR - http://www.scopus.com/inward/record.url?scp=2942517650&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2942517650&partnerID=8YFLogxK

M3 - Article

C2 - 15066926

AN - SCOPUS:2942517650

VL - 13

SP - 607

EP - 612

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 4

ER -